Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma

Published:2022-12-29 Issue: Volume: Page:
ISSN:2095-0217
Container-title:Frontiers of Medicine
language:en
Short-container-title:Front. Med.

Author:

Zhou Yubing,He Xinyu,Jiang Yanan,Wang Zitong,Yu Yin,Wu Wenjie,Zhang Chenyang,Li Jincheng,Guo Yaping,Chen Xinhuan,Liu Zhicai,Zhao Jimin,Liu Kangdong,Dong Zigang

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11684-022-0956-8.pdf

Reference41 articles.

1. Yuan Z, Wang X, Geng X, Li Y, Mu J, Tan F, Xue Q, Gao S, He J. Liquid biopsy for esophageal cancer: is detection of circulating cell-free DNA as a biomarker feasible? Cancer Commun (Lond) 2021; 41(1): 3–15

2. Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 2018; 154(2): 360–373

3. Yang YM, Hong P, Xu WW, He QY, Li B. Advances in targeted therapy for esophageal cancer. Signal Transduct Target Ther 2020; 5(1): 229

4. di Pietro M, Canto MI, Fitzgerald RC. Endoscopic management of early adenocarcinoma and squamous cell carcinoma of the esophagus: screening, diagnosis, and therapy. Gastroenterology 2018; 154(2): 421–436

5. Reichenbach ZW, Murray MG, Saxena R, Farkas D, Karassik EG, Klochkova A, Patel K, Tice C, Hall TM, Gang J, Parkman HP, Ward SJ, Tétreault MP, Whelan KA. Clinical and translational advances in esophageal squamous cell carcinoma. Adv Cancer Res 2019; 144: 95–135

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network pharmacology and molecular docking reveal the mechanisms of curcumin activity against esophageal squamous cell carcinoma;Frontiers in Pharmacology;2024-04-03

2. Risk model based on genes regulating the response of tumor cells to T-cell-mediated killing in esophageal squamous cell carcinoma;Aging;2024-02-01

3. ACAT1 promotes proliferation and metastasis of bladder cancer via AKT/GSK3β/c-Myc signaling pathway;Journal of Cancer;2024

4. N6‐methyladenosine methyltransferase METTL3 modulates the cell cycle of granulosa cells via CCND1 and AURKB in Haimen goats;The FASEB Journal;2023-10-24

5. Patient-derived tumor models: a suitable tool for preclinical studies on esophageal cancer;Cancer Gene Therapy;2023-08-03